FC
BNTX icon

Financial Consulate’s BioNTech BNTX Stock Holding History

Financial Consulate’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4K Hold
370
– – ﹤0.01% 406
2026
Q1 		$32.9K Hold
370
– – ﹤0.01% 393
2025
Q4 		$35.2K Hold
370
– – ﹤0.01% 377
2025
Q3 		$36.5K Buy
+370
New +$39.6K 0.01% 358

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Financial Consulate's BNTX Position: Q2 2026 in Review

Financial Consulate held its BioNTech (BNTX) position steady in Q2 2026 at 370 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Financial Consulate first reported a position in BNTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $36.5K in Q3 2025. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Financial Consulate held 370 shares of BioNTech worth $34.4K as of Q2 2026.
  • Financial Consulate left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #406 holding.
  • Financial Consulate first reported a position in BioNTech in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's BioNTech position peaked at $36.5K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.